PFE Pfizer Inc.

All PFE filings Filing statistics SEC Website

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.

Company profile

Ticker

PFE

Exchange

Incorporated in

Location

Fiscal year end

Industry (SEC)

Pharmaceutical Preparations

Johnson & Johnson • Merck & Co. • Teva Pharmaceutical Industries • Abbott Laboratories • Bristol Myers Squibb • AbbVie • Mylan • Celgene • Endo International • Elanco Animal Health ...

SEC CIK

0000078003

Allogene Therapeutics

PFE stock data

S&P 500 1 month 1 year

Company financial data Financial data

Chart PFE financial data

Download latest Excel data (2019 Q1) View latest Excel data (2019 Q1)

Quarter (USD)	Mar 19	Dec 18	Sep 18	Jul 18
Revenue	13.12B	13.98B	13.3B	13.47B
Net income	3.88B	-393M	4.11B	3.87B
Diluted EPS	0.68	-0.05	0.69	0.65
Net profit margin	29.61%	-2.81%	30.94%	28.75%
Operating income*	4.68B	-588M	4.48B	4.85B
Net change in cash	798M	-2.42B	855M	402M
Cash on hand	1.94B	1.14B	3.56B	2.7B
Cost of revenue	2.43B	3.08B	2.69B	2.92B

Annual (USD)	Dec 18	Dec 17	Dec 16	Dec 15
Revenue	53.65B	52.55B	52.82B
Net income	11.15B	21.31B	7.22B	6.96B
Diluted EPS	1.87	3.52	1.17	1.11
Net profit margin	20.79%	40.55%	13.66%
Operating income*	13.17B	13.53B	9.51B	10.14B
Net change in cash	-203M	-1.25B	-1.05B	298M
Cash on hand	1.14B	1.34B	2.6B	3.64B
Cost of revenue	11.25B	11.23B	12.32B	9.65B

Financial data from Pfizer earnings reports. *Asterisk values are approximate.

Financial report summary

Competition

Akorn • TherapeuticsMD • GT Biopharma • Church & Dwight • Teligent • Cypress Bioscience • Celldex Therapeutics • Poniard Pharmaceuticals • Imclone Systems • Acura Pharmaceuticals

Management Discussion

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
See the Glossary of Defined Terms at the beginning of this Quarterly Report on Form 10-Q for terms used throughout this MD&A. Our MD&A is provided in addition to the accompanying condensed consolidated financial statements and footnotes to assist readers in understanding Pfizer’s results of operations, financial condition and cash flows. The MD&A is organized as follows:
Certain amounts in our MD&A may not add due to rounding. All percentages have been calculated using unrounded amounts.

Content analysis ?

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: accommodate, achondroplasia, adalimumab, Advair, advocacy, Ajanta, alopecia, altering, areata, arm, automate, automation, awaited, azacitidine, Azar, bacteria, Bamboo, began, beta, bioequivalence, bioequivalent, Biopharma, British, cervix, cGMP, Chennai, cohesive, colon, composition, confluence, Congressional, conjugate, costly, counter, coupled, criterion, Cyanamid, deconsolidate, destocking, digestive, digital, draft, dramatic, dramatically, dwarfism, element, emphasized, explicitly, export, fee, fleet, fluticasone, forestalling, Fragmin, framework, frontline, furnished, gBRCA, genetic, Genotropin, globe, Goldman, GSK, harbor, hard, harm, hereditary, hindsight, history, Idec, IKKT, immunotherapy, implicit, Imputed, inception, India, inhalation, Inhub, Irungattukottai, JAVELIN, LA, lactamase, leader, MBC, mCRPC, Medrol, mineral, modest, moved, moving, municipal, mutual, myriad, nmCRPC, nonrecurring, notification, OAI, outweigh, Parliament, path, paused, payor, penalty, persistent, Pharmacology, physician, pilot, powder, preclude, premarket, propionate, prosecution, provincial, Proxy, QCE, RA, realigning, reallocated, Rebif, rectum, refine, refuse, renamed, rent, Residual, retirement, Rheumatology, ROU, safe, salmeterol, SBS, seize, show, side, signal, simplification, skin, solicited, solid, sooner, strictly, sublease, suboptimal, Supreme, susceptibility, tendering, Therachon, TKI, Tygacil, UC, unclear, unconstitutional, unselected, Urbanization, vast, Vietnam, vii, vitamin, Vyndaqel, White, Wixela, WRDM, Xyntha, Zithromax

Removed: acceptable, acceptance, accessible, accreted, accrual, accurate, added, adequately, adjunct, adjuvant, Advil, aggregating, Amerigen, Amsterdam, assertion, assurance, ASU, attained, attempt, authoritative, Avillion, banking, behavior, beneficiary, Besponsa, BLA, bond, borrowed, Bosulif, bowel, broader, Bulletin, buyer, capitalized, CD, ceftaroline, ceiling, Centrum, Chemistry, clarification, CML, collaborated, collateralized, collected, Commencing, commercialize, commercializing, commercially, complexity, concentrated, consolidate, corroborated, counterbalance, Crohn, curtailment, customer, CXL, damage, Darmstadt, deciding, default, denied, Derecognition, designating, designation, designing, destroyed, determinable, diagnosed, diagnostic, diet, dietary, disaggregation, disposition, diversified, diversion, doublet, doughnut, duration, efficiency, eliminated, embedded, ending, enrollment, essentially, Euromonitor, exclusive, exclusively, expanded, expectancy, extension, extinguishment, extract, facilitate, fell, fesoterodine, finalize, forward, fosamil, free, freeze, froze, frozen, gastrointestinal, genuine, glycaemic, glycemic, grand, granting, Guaranty, hierarchy, highlighted, hole, Honjo, hospitalized, identical, identified, imposing, impracticable, inappropriate, incurring, inflammatory, initially, innovating, inoperability, inoperable, inside, Inspra, institute, instrument, interpretation, interval, intolerance, invoiced, Israel, issuer, Januvia, joined, jury, kidney, lack, lag, lapse, Leading, legislated, lessee, lessor, lifting, liquidation, loan, London, lorlatinib, low, lymphoblastic, maintained, marketability, maximally, Medication, meropenem, metformin, Mexico, missing, month, movement, mutation, Mylotarg, narrowed, nephrectomy, Nivestim, nonfinancial, NovaQuest, novo, observable, offer, offsetting, Ono, operationally, opposite, orderly, original, passage, patented, performing, persuasive, Ph, Philadelphia, pool, practicable, precursor, preliminary, prepayment, prescriber, priority, produced, prohibition, prolonging, promissory, promyelocytic, proper, proportion, provisional, psoriatic, publication, ratably, ratio, reaching, readily, reclassifying, refractory, refunded, regimen, relapsed, relocating, remitted, repaid, representation, requesting, residential, restriction, resumed, Retacrit, retail, returned, Revatio, reverse, RPI, Russia, secured, Segluromet, selectively, seller, sensitivity, sham, shelf, shipment, shipped, shorter, sitagliptin, splitting, spot, Squibb, stable, Steglatro, Steglujan, stranded, StratCO, strike, strove, student, SU, suggested, sulphonylurea, summarized, supported, surgical, swap, Tasuku, temporary, title, titled, tolerated, tool, Topic, Torrent, Toviaz, Track, Trading, transfer, transitional, UCB, unbudgeted, undertaken, underway, unlimited, unpatented, untreated, upholding, vendor, watch, whichever, withdrew, WRD, Zavicefta, zeta, Zinforo

From filing 10-Q 2019 Q1